2023-2030 年全球携带式静脉查找仪市场

概述

全球便携式静脉查找器市场于 2022 年达到 100 万美元，预计到 2030 年将达到 100 万美元，在 2023-2030 年预测期内复合年增长率为 100%。

便携式静脉查找器透过显示患者皮肤上静脉的即时影像来定位静脉。静脉查找器通常不是便携式的，但便携式静脉查找器在医院环境中为不同患者进行静脉穿刺技术时很容易随身携带。这些也称为静脉照明器，因为它们使用透射照明技术来观察皮肤表面的静脉。

静脉观察器可提高准确性、最大程度地减少不适并降低静脉穿刺的风险。抽血医师主要使用静脉观察器来帮助定位静脉进行抽血，从而提高手术的成功率。静脉侦测器可减少併发症、提高病患满意度并提高首次尝试的成功率。

市场动态：驱动因素与限制因素

增加住院人数

疫情期间住院和定期医疗检查的人数增加。人们对健康意识的不断增强使得人们定期去看医生。静脉探查器用于为患者抽血、静脉穿刺等，对患者进行诊断、监测、治疗等目的。住院人数的增加增加了静脉侦测器的使用，进一步推动了市场的发展。

例如，根据美国医院协会的数据，2023 年，根据 6,200 多家医院和 400 个医疗保健系统提供的资料，美国所有医院的入院总人数为 34,011,386 人。

此外，根据世界卫生组织的数据，2023年，在全球范围内，过去28天内（2023年8月至9月），共有95 999例新增住院病例和985例新增ICU入院病例，增加了42 %，与前 28 天（2023 年 7 月至 8 月）相比分别成长了 12%。

根据澳洲健康与福利研究所的数据，2023年，2021-22年公立和私立医院入院人数为1,160万人，较上年下降2.1%。在此之前，2019-20 年至 2020-21 年成长了 6.3%。

首次尝试在深色皮肤人群中失败

中度或深色肤色的患者首次静脉注射 PIV 导管插入的成功率为 57%，而浅肤色患者的成功率为 78%。深色或中等肤色患者的成功率接近57.1%，比浅肤色患者的成功率（78%）低21%。据 Accuvein 称，深色皮肤色素沉着患者的首次尝试失败率高达 21%。静脉侦测器在暗色和深色肤色上不太可行，因为在深色肤色的人中看不到照明光。

有关此报告的更多详细资讯 - 索取样品

目录

第 1 章：方法与范围

• 研究方法论
• 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

• 按产品类型分類的片段
• 技术片段
• 最终使用者的片段
• 按地区分類的片段

第 4 章：动力学

• 影响因素
  • 司机
    • 增加住院人数
    • YY
  • 限制
    • 首次尝试在深色皮肤人群中失败
    • YY
  • 机会
  • 影响分析

第 5 章：产业分析

• 波特五力分析
• 供应链分析
• 定价分析
• 监管分析
• DMI 意见

第 6 章：COVID-19 分析

• COVID-19 分析
  • 新冠疫情爆发前的情景
  • 新冠疫情期间的情景
  • 新冠疫情后的情景
• COVID-19 期间的定价动态
• 供需谱
• 疫情期间政府与市场相关的倡议
• 製造商策略倡议
• 结论

第 7 章：按产品类型

• 显示类型
• 无显示型

第 8 章：按技术

• 近红外线
• 可见光透射照明
• 其他的

第 9 章：最终用户

• 医院和诊所
• 诊断中心和研究中心
• 其他的

第 10 章：按地区

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地区
• 亚太
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 亚太其他地区
• 中东和非洲

第 11 章：竞争格局

• 竞争场景
• 市场定位/份额分析
• 併购分析

第 12 章：公司简介

• AccuVein, Inc
• 公司简介
• 产品组合和描述
• 财务概览
• 主要进展
• Christie Medical Holdings Inc.
• Novarix
• TransLite
• Vuetek
• AMBULANC (SHENZHEN) TECH. CO. LTD.ZD Medical
• BLZ Technology
• B. Braun Medical Inc.
• Thermo Fisher Scientific Inc
• Delta Medical International Ltd

第 13 章：附录

Overview

Portable vein finder locates veins by showing real-time images of veins on the patient's skin. Vein finders are not often portable, but portable ones are easy to carry around during the venipuncture techniques for different patients in hospital settings. These are also called vein illuminators, as they use trans-illumination technology to view the veins on the skin's surface.

Vein viewers enhance accuracy, minimize discomfort, and reduce the risk of venipunctures. Phlebotomists mainly use vein viewers to help locate veins for blood draws, which improves the procedure's success rate. Vein finders reduce complications, increase patient satisfaction, and increase first-attempt success.

Market Dynamics: Drivers & Restraints

Increasing hospital admissions

The number of hospitalizations and regular healthcare checkups increased during the pandemic. The growing awareness about health among people is making people regularly visit doctors. Vein finders are used for patients to draw blood, venipuncture, etc., which is done to patients for diagnosis, monitoring, and treatment purposes. Increased hospital admissions increase the use of vein finders, further driving the market.

For instance, according to the American Hospital Association, 2023, per the data provided by over 6,200 hospitals and 400 healthcare systems, total admissions in all U.S. hospitals are 34,011,386.

Furthermore, according to the World Health Organization, 2023, At the global level, during the past 28 days (August to September 2023), a total of 95 999 new hospitalizations and 985 new ICU) admissions were reported, an increase of 42% and 12% respectively, compared to the previous 28 days (July to August 2023).

According to the Australian Institute of Health and Welfare, 2023, there were 11.6 million public and private hospital admissions in 2021-22, a 2.1% decrease from the previous year. This followed a 6.3% increase from 2019-20 to 2020-21.

First attempt failure in dark-skinned people

Patients with medium or dark skin color had a first IV attempt success rate of 57% for PIV catheter insertions, while fair skin color patients had a rate of 78%. The success rate for patients with dark or medium skin color was nearly 57.1%, which was 21% less than the success rate for those with light skin color (78%). According to Accuvein, the first stick attempt failure rate is up to 21% higher in patients with dark skin pigmentation. Vein finders are not so feasible on dusky and dark skin tones because the illuminated light is not visible in dark-skin-toned people.

For more details on this report - Request for Sample

Segment Analysis

The global portable vein finder is segmented based on product type, technology, end-user and region.

The transillumination segment accounted for approximately 47.3% of the market share

Transillumination uses light to illuminate the veins. The image is due to deoxyhemoglobin in the venous blood, which absorbs red light and radiates the veins as dark lines on the skin's surface. This is the easiest and most reliable way of accessing the vein on the skin's surface. Launching the vein finders using transillumination technology makes the work of clinicians easy due to its efficiency.

In April 2022, ImmunoTek Bio Centers launched the first blood plasma collection centers using VeinViewer, developed by Christie Medical Holdings, which provides phlebotomists with real-time images of the donor's veins before needle insertion.

In September 2021, NextVein LLC launched a product that makes vein visualization affordable for every clinician. The NextVein system is designed from the ground up to be a simple-to-use, cost-effective solution for successful vein access.

Geographical Analysis

North America accounted for approximately 40.2% of the market share in 2022

Hospital admissions in the U.S. increased drastically in 2021; there were over 34 million hospital admissions in the United States. The number of hospitals in the U.S. has decreased in recent years, although the country faces an increasing elderly population. Predictably, the elderly account for the largest share of hospital admissions in the U.S.

For instance, according to the report published in 2023 by the Centers for Disease Control and Prevention (CDC), the total number of hospitalizations from COVID-19, flu, and syncytial virus infections this year, similar to last year, higher than pre-pandemic levels.

Although COVID-19 hospitalizations have drastically decreased since 2022, there is an increase in awareness about healthcare checkups after the pandemic. Moreover, there is an increased geriatric population in the United States and the rest of the world; hence, North America holds the largest share of the market.

COVID-19 Impact Analysis:

COVID-19 created a surge in the portable vein finder market. The number of patients visiting hospitals increased during the pandemic, which increased the use of hospital equipment and medical devices. Vein finders allow physicians to access veins easily within less time, which is less time-consuming than manually finding them on patients' skin. For almost all patients, these medical devices are used to access the vein quickly. This has increased the demand for portable vein finders during the pandemic period.

Competitive Landscape

The major global players in the portable vein finder market include: AccuVein, Inc, Christie Medical Holdings Inc., Novarix, TransLite, Vuetek, AMBULANC (SHENZHEN) TECH. CO. LTD.ZD Medical, BLZ Technology, B. Braun Medical Inc., ThermoFisher Scientific Inc, Delta Medical International Ltd among others.

Key Developments

• In October 2022, Right Way Medical, a medical device distributor is in partnership with NextVein, to increase patient satisfaction. It uses augmented reality to project the vein pattern on patient skin, bringing clarity and simplicity to clinicians.

Why Purchase the Report?

• To visualize the global portable vein finder market segmentation based on product type, technology, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of portable vein finder market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global portable vein finder market report would provide approximately 61 tables, 51 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Driver
    • 4.1.1.1. Increasing hospital admissions
    • 4.1.1.2.
  • 4.1.2. Restraints
    • 4.1.2.1. First attempt failure in dark-skinned people
    • 4.1.2.2.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Display type*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Non-Display Type

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 8.1.2. Market Attractiveness Index, By Technology
• 8.2. Near-infrared*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Visible light trans illumination
• 8.4. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals and Clinics*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Diagnostic centers and Research Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. AccuVein, Inc
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Christie Medical Holdings Inc.
• 12.3. Novarix
• 12.4. TransLite
• 12.5. Vuetek
• 12.6. AMBULANC (SHENZHEN) TECH. CO. LTD.ZD Medical
• 12.7. BLZ Technology
• 12.8. B. Braun Medical Inc.
• 12.9. Thermo Fisher Scientific Inc
• 12.10. Delta Medical International Ltd

LIST NOT EXHAUSTIVE.

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us